IRIS
CLEMENTI, MASSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 6.226
NA - Nord America 3.814
EU - Europa 2.855
SA - Sud America 1.834
AF - Africa 118
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 1
Totale 14.859
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.633
SG - Singapore 2.637
CN - Cina 1.693
BR - Brasile 1.533
SE - Svezia 1.093
HK - Hong Kong 910
VN - Vietnam 516
IT - Italia 503
RU - Federazione Russa 366
DE - Germania 274
FI - Finlandia 129
GB - Regno Unito 129
IN - India 116
AR - Argentina 114
CA - Canada 89
EC - Ecuador 61
PL - Polonia 60
MX - Messico 58
BD - Bangladesh 56
ID - Indonesia 56
IE - Irlanda 51
AT - Austria 47
ZA - Sudafrica 47
ES - Italia 41
FR - Francia 40
IQ - Iraq 39
NL - Olanda 36
JP - Giappone 34
TR - Turchia 32
CO - Colombia 31
UZ - Uzbekistan 30
PY - Paraguay 26
VE - Venezuela 23
MA - Marocco 21
PK - Pakistan 18
UA - Ucraina 18
CL - Cile 16
LT - Lituania 15
SA - Arabia Saudita 14
TN - Tunisia 13
UY - Uruguay 13
PE - Perù 12
RO - Romania 12
DZ - Algeria 10
PH - Filippine 10
JM - Giamaica 9
JO - Giordania 9
AU - Australia 8
BE - Belgio 8
EG - Egitto 8
AE - Emirati Arabi Uniti 7
DO - Repubblica Dominicana 6
AZ - Azerbaigian 5
GA - Gabon 5
HU - Ungheria 5
IR - Iran 5
KE - Kenya 5
KZ - Kazakistan 5
NI - Nicaragua 5
NP - Nepal 5
AL - Albania 4
BG - Bulgaria 4
BO - Bolivia 4
IL - Israele 4
LB - Libano 4
BB - Barbados 3
BY - Bielorussia 3
GE - Georgia 3
GT - Guatemala 3
KW - Kuwait 3
SN - Senegal 3
TT - Trinidad e Tobago 3
BH - Bahrain 2
BN - Brunei Darussalam 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
GR - Grecia 2
HN - Honduras 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
RS - Serbia 2
SI - Slovenia 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
CH - Svizzera 1
CI - Costa d'Avorio 1
ET - Etiopia 1
EU - Europa 1
GY - Guiana 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
ME - Montenegro 1
MN - Mongolia 1
MU - Mauritius 1
MY - Malesia 1
NO - Norvegia 1
Totale 14.851
Salva come PNG Salva come JPEG
Città #
Singapore 1.068
Hong Kong 907
Dallas 870
Ashburn 494
Shanghai 464
Hefei 384
Princeton 359
Lawrence 356
Beijing 230
Ho Chi Minh City 211
Milan 206
New York 184
Moscow 142
São Paulo 137
Hanoi 111
Los Angeles 105
Helsinki 97
Munich 72
Nuremberg 62
Warsaw 58
Dublin 48
Denver 41
Rio de Janeiro 41
Brasília 40
Boardman 38
Poplar 36
Pune 36
Seattle 35
Montreal 34
Stockholm 34
Belo Horizonte 33
Chennai 33
Rome 33
London 32
Orem 32
Santa Clara 32
Tokyo 31
Boston 30
Johannesburg 30
Tashkent 28
Washington 27
Guangzhou 25
Turku 25
Atlanta 24
Bologna 24
Porto Alegre 23
Brooklyn 22
Quito 22
Shenzhen 21
Toronto 21
Brescia 20
Guayaquil 20
Ancona 19
Guarulhos 19
Vienna 19
Biên Hòa 18
Chicago 18
Falkenstein 18
Ankara 17
Manaus 17
Salvador 17
Tianjin 17
Campinas 16
Da Nang 16
Houston 16
Mexico City 16
Amsterdam 15
Cesano Boscone 15
Frankfurt am Main 15
Haiphong 15
Ribeirão Preto 15
Manchester 14
The Dalles 14
Phoenix 13
Caxias do Sul 12
Curitiba 12
Hangzhou 12
Joinville 12
Sorocaba 12
Buenos Aires 11
Columbus 11
Contagem 11
Florianópolis 11
Fortaleza 11
Hải Dương 11
Ninh Bình 11
Recife 11
San Francisco 11
Santo André 11
Thái Bình 11
Borås 10
Montevideo 10
Querétaro 10
Amman 9
Aracaju 9
Asunción 9
Baghdad 9
Bogotá 9
Council Bluffs 9
Dhaka 9
Totale 8.121
Salva come PNG Salva come JPEG
Nome #
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 133
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 109
The interferon landscape along the respiratory tract impacts the severity of COVID-19 100
48 week outcomes of maraviroc-containing regimens following the genotypic or Trofile assay in HIV-1 failing subjects: the OSCAR Study 98
Interferon-β 1a inhibits SARS-CoV-2 in vitro when administered after virus infection 97
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 95
Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls 95
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects 92
Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: Epitope definition and implications in risk stratification of patients under natalizumab therapy 90
Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19 90
Biobanking for COVID-19 research 86
A Biologically-validated HCV E1E2 Heterodimer Structural Model 86
Nanopore ReCappable sequencing maps SARS-CoV-2 5' capping sites and provides new insights into the structure of sgRNAs 86
A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments 85
A Human Stem Cell-Derived Neurosensory–Epithelial Circuitry on a Chip to Model Herpes Simplex Virus Reactivation 83
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 80
A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses 79
Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies 79
Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection 79
2-Aminothiazolones as Anti-HIV Agents That Act as gp120-CD4 Inhibitors 77
Cytomegalovirus-specific T cells restricted for shared and donor human leukocyte antigens differentially impact on Cytomegalovirus reactivation risk after allogeneichematopoietic stem cell transplantation 76
Broadly neutralizing anti-influenza human monoclonal antibodies and their possible role in predictive medicine 76
A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes 75
Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro 75
Laparoscopic right hemicolectomy: the SICE (Società Italiana di Chirurgia Endoscopica e Nuove Tecnologie) network prospective trial on 1225 cases comparing intra corporeal versus extra corporeal ileo-colic side-to-side anastomosis 75
Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes 75
Antibiotic appropriateness for Gram-negative bloodstream infections: impact of infectious disease consultation 73
Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy 73
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion? 72
A potential role for monoclonal antibodies in prophylactic and therapeutic treatment of influenza 72
Differential composition of vaginal microbiome, but not of seminal microbiome, is associated with successful intrauterine insemination in couples with idiopathic infertility: A prospective observational study 72
Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin 72
Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections 71
JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes? 71
Analysis of the faecal microbiome during analytical treatment interruption in people with chronic HIV infection and long-lasting virological suppression (APACHE study) 71
A vector for the expression of recombinant monoclonal Fab fragments in bacteria 70
Lower nasopharyngeal viral load during the latest phase of COVID-19 pandemic in a Northern Italy University Hospital 70
"Low-grade positivity" of HPV viral load after atypical squamous cells of undetermined significance (ASC-US) cytology identifies women at low-risk for cervical intraepithelial neoplasia grade 2 and 3 69
IFCC interim guidelines on biochemical/hematological monitoring of COVID-19 patients 69
Adaptive immunity against gut microbiota enhances apoE-mediated immune regulation and reduces atherosclerosis and western-diet-related inflammation 68
Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials 68
Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort Study 67
IN VIVO PROTECTION CONFERRED BY HUMAN MONOCLONAL ANTIBODY DIRECTED AGAINST HSV-1 AND 2 67
Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects 67
A combination of nucleoside analogues and a protease inhibitor reduces HIV-1 RNA levels in semen: implications for sexual transmission of HIV infection 66
Acute respiratory distress in a neutropenic febrile patient after hematopoietic cell transplantation 66
A recombinant human Fab inhibits activity of HCVNS3 and negative strand RNA synthesis 65
A closer look at prion strains: Characterization and important implications 65
Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge 65
A case of psoriatic arthritis triggered by SARS-CoV-2 infection 65
Characterization of GBV-C infection in HIV-1 infected patients 64
A recombinant human Fab inhibits helicase activity of HCVNS3 and negative strand RNA synthesis 64
Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols 64
Human herpesvirus 6-specific T-cell immunity in allogeneic hematopoietic stem cell transplant recipients 63
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein 63
A recombinant human Fab inhibits helicase activity of HCVNS3 and negative strand RNA synthesis 62
Sex-specific Alterations in the Urinary and Tissue Microbiome in Therapy-naïve Urothelial Bladder Cancer Patients 62
A SINGLE-STEP DNA EXTRACTION PROCEDURE FOR THE DETECTION OF SERUM HEPATITIS-B VIRUS SEQUENCES BY THE POLYMERASE CHAIN-REACTION 61
A NOVEL PROCEDURE FOR QUANTITATIVE POLYMERASE CHAIN-REACTION BY COAMPLIFICATION OF COMPETITIVE TEMPLATES 61
Broad-range neutralizing anti-influenza A human monoclonal antibodies: new perspectives in therapy and prophylaxis. 61
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases 59
Laparoscopic right hemicolectomy: a SICE (Società Italiana di Chirurgia Endoscopica e Nuove tecnologie) network prospective study on the approach to right colon lymphadenectomy in Italy: is there a standard?—CoDIG 2 (ColonDx Italian Group) 58
Smallpox vaccination-elicited antibodies cross-neutralize 2022-Monkeypox virus Clade II 58
Antigen-driven evolution of B lymphocytes in coronary atherosclerotic plaques 58
Absence of HHV-6 and HHV-7 in cerebrospinal fluid in relapsing-remitting multiple sclerosis 58
Characterization of two human monoclonal anti-E2/HCV antibodies for potential application in prevention and treatment of HCV infection 57
Anti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding site 57
Answer to February 2019 Photo Quiz: Neurological Symptoms in a 74-Year-Old Diabetic Woman Admitted to the Emergency Room 56
Molecular characterization of the human neutralizing response against hepatitis C virus and its role in the prediction of the infection outcome 56
Epitope mapping by epitope excision, hydrogen/deuterium exchange, and peptide-panning techniques combined with in silico analysis 55
Adjuvant role of SeptiFast to improve the diagnosis of sepsis in a large cohort of hematological patients 54
Three-row versus two-row circular staplers for left-sided colorectal anastomosis: a propensity score-matched analysis of the iCral 2 and 3 prospective cohorts 53
Epidemiological and Clinical Features of SARS-CoV-2 Variants Circulating between April-December 2021 in Italy 53
Amotosalen Photochemical Inactivation of Severe Acute Respiratory Syndrome CoronaVirus (SARS-CoV) in Human Platelet Concentrates 53
Role and potential therapeutic use of antibodies against herpetic infections 53
Microbiome Markers are Early Predictors of Acute GvHD in Allogeneic Hematopoietic Stem Cell Transplant recipients 53
Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro 52
Circulating SARS-CoV-2 variants in Italy, October 2020–March 2021 52
Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2 51
Identification of a novel mutation involved in colistin resistance in Klebsiella pneumoniae through Next-Generation Sequencing (NGS) based approaches 51
Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines 51
Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies 51
Coronaviridae and SARS-associated coronavirus strain HSR1 51
A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum 51
Very high SARS-CoV-2 load at the emergency department presentation strongly predicts the risk of admission to the intensive care unit and death 50
Clinical characterization and whole genome sequence-based typing of two cases of endophthalmitis due to Listeria monocytogenes 49
Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools 49
An update on integrase inhibitors: new opportunities for a personalized therapy? The NEXTaim Project. 49
HCV E2 core structures and mAbs: something is still missing 49
Improving the Diagnostic Algorithm for Sepsis: Adjuvant Role of SeptiFast in 491 Consecutive Hematological Patients 49
Western blot in treated people with HIV-1 chronic infection: frequency of negative HIV-1 pol genes 49
Characterization of a lineage c.36 sars-cov-2 isolate with reduced susceptibility to neutralization circulating in lombardy, italy 48
Vinegar and its active component acetic acid inhibit SARS-CoV-2 infection in vitro and ex vivo 48
Human monoclonal recombinant antibody against NS3 HCV protein and methods therefor 47
Unveiling the role of PUS7-mediated pseudouridylation in host protein interactions specific for the SARS-CoV-2 RNA genome 46
Virus-induced preferential antibody gene-usage and its importance in humoral autoimmunity 46
Anti-HCV monoclonal antibody as a medicament for the therapeutic treatment and prevention of HCV infections 46
Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogens 46
Method for the preparation of new oligoclonal antibodies 45
Evolution patterns of raltegravir-resistant mutations after integrase inhibitor interruption 45
Totale 6.612
Salva come PNG Salva come JPEG
Categoria #
all - tutte 137.193
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 137.193
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202156 0 0 0 0 0 15 17 13 1 7 2 1
2021/2022232 6 3 20 72 19 18 15 15 12 18 8 26
2022/20231.989 811 463 167 18 26 224 71 112 71 5 13 8
2023/2024936 21 44 151 95 68 228 22 79 5 41 45 137
2024/20254.713 607 80 49 131 126 406 619 451 911 618 314 401
2025/20267.048 1.118 1.229 1.224 2.142 1.033 302 0 0 0 0 0 0
Totale 15.183